2023
Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence
Oliveira D, Fontenele R, Weleff J, Sofuoglu M, De Aquino J. Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence. International Review Of Psychiatry 2023, 35: 377-396. PMID: 38299655, PMCID: PMC10835074, DOI: 10.1080/09540261.2023.2229430.Peer-Reviewed Original ResearchOpioid agonist therapyOpioid use disorderNon-opioid analgesicsUse disordersNon-opioid analgesic therapyAlpha-2 adrenergic agonistsMajor public health concernGlial activation inhibitorNon-opioid therapeuticsNovel analgesic strategiesPotential of cannabinoidsPrior opioid exposureOpioid-dependent individualsOpioid-dependent populationsAbuse liability assessmentPublic health concernAnalgesic strategiesAgonist therapyAnalgesic therapyOpioid exposureOUD treatmentPharmacokinetic interactionsGABAergic drugsSignificant morbidityPain types
2022
Black Pepper (Piper nigrum) for Tobacco Withdrawal: A Case Report
Weleff J, Dore S, Anand A, Barnett B. Black Pepper (Piper nigrum) for Tobacco Withdrawal: A Case Report. Case Reports In Psychiatry 2022, 2022: 5908769. PMID: 36530582, PMCID: PMC9757938, DOI: 10.1155/2022/5908769.Peer-Reviewed Original ResearchNicotine withdrawalTobacco withdrawalWithdrawal-associated anxietyTobacco use disorderTreating nicotine withdrawalNicotine cravingTobacco cigarettesUse disorderSensorimotor experienceEffective novel treatmentCravingMotor urgeSignificant public health concernSmall clinical trialsCorrectional settingsNonresearch settingsWithdrawalCase reportClinical trialsPublic health concernNovel treatmentCorrectional facilitiesPatient reportsTobacco cessationTobacco use